STING1 and neoplasm: STING plays a crucial role in the detection of cytosolic DNA and the activation of the innate immune response [45]; preclinical studies [6,33,46] have demonstrated that DMXAA or ADU-S100 (STING agonists) have a significant anti-tumor effect [26,27,47].